Logos Global Management’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.3M Buy
+175,000
New +$38.1M 1.68% 21
2020
Q1
– Sell
-124,937
Closed -$12.9M – 46
2019
Q4
$12.9M Buy
+124,937
New +$5.05M 3.18% 14

Other funds holding AXSM

Logos Global Management's AXSM Position: Q3 2026 in Review

Logos Global Management opened a new position in Axsome Therapeutics (AXSM) in Q3 2026: 175,000 shares worth $32.3M. The stake represents 1.68% of the portfolio and ranks #21 among its holdings. This is a return to the name: Logos Global Management previously reported a position in AXSM as recently as Q4 2019.

Logos Global Management first reported a position in AXSM in Q4 2019 and has held it in 2 quarters since. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Logos Global Management held 175,000 shares of Axsome Therapeutics worth $32.3M as of Q3 2026.
  • Axsome Therapeutics was a new Logos Global Management position in Q3 2026.
  • Axsome Therapeutics made up 1.68% of Logos Global Management's portfolio in Q3 2026, its #21 holding.
  • Logos Global Management first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 2 quarters since.
  • 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Logos Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.